Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia

Author:

Wang Jiguang123,Khiabanian Hossein123,Rossi Davide4,Fabbri Giulia56,Gattei Valter7,Forconi Francesco89,Laurenti Luca10,Marasca Roberto11,Del Poeta Giovanni12,Foà Robin13,Pasqualucci Laura56,Gaidano Gianluca4,Rabadan Raul123

Affiliation:

1. Department of Biomedical Informatics, Columbia University, New York, United States

2. Department of Systems Biology, Columbia University, New York, United States

3. Center for Computational Biology and Bioinformatics, Columbia University, New York, United States

4. Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

5. Institute for Cancer Genetics, Columbia University, New York, United States

6. Department of Pathology and Cell Biology, Columbia University, New York, United States

7. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Aviano, Italy

8. Cancer Sciences Unit, Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom

9. Haematology Department, Southampton University Hospital Trust, Southampton, United Kingdom

10. Institute of Hematology, Catholic University of the Sacred Heart, Rome, Italy

11. Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy

12. Department of Hematology, Tor Vergata University, Rome, Italy

13. Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Abstract

Cancer is a clonal evolutionary process, caused by successive accumulation of genetic alterations providing milestones of tumor initiation, progression, dissemination, and/or resistance to certain therapeutic regimes. To unravel these milestones we propose a framework, tumor evolutionary directed graphs (TEDG), which is able to characterize the history of genetic alterations by integrating longitudinal and cross-sectional genomic data. We applied TEDG to a chronic lymphocytic leukemia (CLL) cohort of 70 patients spanning 12 years and show that: (a) the evolution of CLL follows a time-ordered process represented as a global flow in TEDG that proceeds from initiating events to late events; (b) there are two distinct and mutually exclusive evolutionary paths of CLL evolution; (c) higher fitness clones are present in later stages of the disease, indicating a progressive clonal replacement with more aggressive clones. Our results suggest that TEDG may constitute an effective framework to recapitulate the evolutionary history of tumors.

Funder

National Center for Advancing Translational Sciences

National Institutes of Health

Associazione Italiana per la Ricerca sul Cancro

Ministero dell'Istruzione, dell'Università e della Ricerca

Istituto Nazionale di Fisica Nucleare

Ministero della Salute

Alexander and Margaret Stewart Trust

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3